Global Antibiotic R&D Partnership (GARDP)
Cristina Praz is an experienced professional in external relations, fundraising, and communication, currently serving as External Relations Manager at the Global Antibiotic R&D Partnership since January 2021. Prior roles include External Relations Consultant and various positions at UNICEF, where responsibilities encompassed donor relations and advocacy strategies for child rights. Additional experience includes managing partnerships and grants at CCBRT in Tanzania, and prior engagement in political affairs and human rights with the Swiss Foreign Affairs Ministry and Europe-Third World Center. Cristina holds a Master's degree in International Relations and Affairs from the Geneva Graduate Institute, and a Bachelor's degree in Economic and Social Sciences from the University of Geneva.
Global Antibiotic R&D Partnership (GARDP)
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. www.gardp.org